Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.
about
Neural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot studyMild cognitive impairment: pathology and mechanisms.Specific and disease stage-dependent episodic memory-related brain activation patterns in Alzheimer’s disease: a coordinate-based meta-analysisImbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneusCortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease.Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjectsResilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's diseaseDisrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease.Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer diseasePostmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.Maternal family history is associated with Alzheimer's disease biomarkersAltered regional homogeneity in patients with unilateral acute open-globe injury: a resting-state functional MRI studyTwo-dimensional enrichment analysis for mining high-level imaging genetic associations.Early and Late Pathomechanisms in Alzheimer's Disease: From Zinc to Amyloid-β NeurotoxicitySynapse stability in the precuneus early in the progression of Alzheimer's diseaseRetinoic acid as a therapeutic option in Alzheimer's disease: a focus on cholinergic restoration.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and (18)F-FDG PET Study.Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.Visual reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer's disease in Japanese patients with mild cognitive impairments.Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.Impaired cortical oscillatory coupling in mild cognitive impairment: anatomical substrate and ApoE4 effects.Choline and the Brain: An Epigenetic Perspective.Inflection Point in Course of Mild Cognitive Impairment: Increased Functional Connectivity of Default Mode Network.Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications
P2860
Q24596119-1A61A70B-1183-46FF-B71A-C496DD3CAD5BQ24631255-60438586-8D67-4181-8B22-110AB86F9E1CQ24758018-8A2A3C76-A3D3-460B-BACE-2ECB4944048AQ28544853-3405D10B-DA54-4E6A-9BDB-F72A0B7D16DCQ30361851-908CC16C-7A62-41BC-B4AF-77F454555FAAQ33882427-6964DD00-73D9-49CD-A309-A5D6FBEFDB94Q33895321-67446512-E09B-43EB-9C5B-8653A49F81EDQ33998690-2226F7DE-C278-4115-B08B-E4E7AEB6299CQ35035669-275C4A43-393E-4BC7-98E5-3E07F4D07054Q36256485-B8623588-94C6-407E-B6F2-3E0A063E2FDAQ36347400-9F511828-B27B-4BF3-B4EE-042DD4A9BEE6Q36713678-F894D298-32A5-47FD-9613-FB131C77C079Q36717013-DF7AEB96-5388-4EB8-ACEC-070E7AFF8C3FQ37154998-8746920E-1AF5-455B-91A2-DAC69120FFA8Q37427196-96ECE6E1-38D2-4D5D-9D9E-CF424F425F61Q37710159-046C62AB-91C8-4909-9B94-9FAB468246DBQ37724226-2579CDB5-CF6D-4B16-BB39-466230F3A963Q38356258-2EF466FE-D913-4360-B672-53E6901CA88BQ38836004-0E42640C-B3A4-4963-9086-B850A639A89CQ38979999-3B8257AF-FA6D-468A-825B-C43C480F504CQ39460000-0FD2BD90-D19F-4396-9B4C-CF134C9CB8F6Q40506883-6BD58656-AA05-45F9-B29C-022CD1D7EA79Q41949381-5EE97A55-D7B4-4015-8B34-1F0BDD3E7549Q43058539-3B4DCB44-ED51-488A-8355-55F700C5EB05Q43928650-02ABCDCC-459F-4B42-851D-B9155F3A66C1Q44269590-A9791FD3-7725-4CBC-8B5D-9DE34D8617C3Q44556621-E248689E-F7F7-45A2-925E-882210F33825Q47932666-82623303-0AE2-4E51-A652-BE05E99CEE92Q48128127-77914EFA-B5D1-42BB-B62E-4B5FD96D37B5Q48531560-9FAB4273-683C-4805-8917-81A197F08F46Q58754278-DA0BF734-6324-46AA-B9FE-91D7AE3A79A0
P2860
Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Precuneus amyloid burden is as ...... activity in Alzheimer disease.
@ast
Precuneus amyloid burden is as ...... activity in Alzheimer disease.
@en
type
label
Precuneus amyloid burden is as ...... activity in Alzheimer disease.
@ast
Precuneus amyloid burden is as ...... activity in Alzheimer disease.
@en
prefLabel
Precuneus amyloid burden is as ...... activity in Alzheimer disease.
@ast
Precuneus amyloid burden is as ...... activity in Alzheimer disease.
@en
P2093
P2860
P1433
P1476
Precuneus amyloid burden is as ...... activity in Alzheimer disease
@en
P2093
C A Mathis
E E Abrahamson
E J Mufson
M D Ikonomovic
S W Scheff
P2860
P356
10.1212/WNL.0B013E3182231419
P407
P577
2011-06-22T00:00:00Z